Study on effect of calcium supplementation on pregnant wome
- Conditions
- Health Condition 1: O269- Pregnancy related conditions, unspecified
- Registration Number
- CTRI/2022/12/047860
- Lead Sponsor
- G.C Chemie Pharmie Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Pregnant females between the ages of >=18 and 40 years (both inclusive) willing to participate in study and provide written informed consent.
2. Pregnant women at 20th weeks attending antenatal care visit (ANC) visit at study clinics.
1. No medical contraindications to continuing pregnancy.
2. Treatment with antitubercular and anti-epileptic drugs.
3. History of pre-eclampsia & eclampsia
4. History or signs and/or symptoms of nephrolithiasis
5. Prior diagnosis of parathyroid disorder or thyroidectomy
6. Diseases that require digoxin, phenytoin, or tetracycline therapy
7. History of chronic liver disease
8. History of renal disease & no known uterine anomaly
9. No history of cervical conization
10. Obesity (BMI 30.0 and higher)
11. Diagnostic history of Type I & Type II Diabetes
12. Diagnostic history of hypertension
13. History of any autoimmune disease
14. Subject with multiple pregnancy.
15. Diagnostic history of fetal anomalies.
16. Any other condition that in the opinion of the
investigator does not justify the patients participation in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method